- Home
- ETJ vs CDNA Comparison
ETJ vs CDNA Comparison
Compare ETJ & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETJ
- CDNA
- Stock Information
- Founded
- ETJ 2007
- CDNA 1998
- Country
- ETJ United States
- CDNA United States
- Employees
- ETJ N/A
- CDNA N/A
- Industry
- ETJ Finance Companies
- CDNA Medical Specialities
- Sector
- ETJ Finance
- CDNA Health Care
- Exchange
- ETJ Nasdaq
- CDNA Nasdaq
- Market Cap
- ETJ 603.7M
- CDNA 712.2M
- IPO Year
- ETJ N/A
- CDNA 2014
- Fundamental
- Price
- ETJ $8.99
- CDNA $13.66
- Analyst Decision
- ETJ
- CDNA Buy
- Analyst Count
- ETJ 0
- CDNA 7
- Target Price
- ETJ N/A
- CDNA $27.67
- AVG Volume (30 Days)
- ETJ 175.6K
- CDNA 1.5M
- Earning Date
- ETJ 01-01-0001
- CDNA 08-06-2025
- Dividend Yield
- ETJ 8.30%
- CDNA N/A
- EPS Growth
- ETJ N/A
- CDNA N/A
- EPS
- ETJ N/A
- CDNA 1.00
- Revenue
- ETJ N/A
- CDNA $340,826,000.00
- Revenue This Year
- ETJ N/A
- CDNA $13.02
- Revenue Next Year
- ETJ N/A
- CDNA $12.85
- P/E Ratio
- ETJ N/A
- CDNA $13.69
- Revenue Growth
- ETJ N/A
- CDNA 14.72
- 52 Week Low
- ETJ $7.20
- CDNA $10.96
- 52 Week High
- ETJ $8.47
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- ETJ 53.08
- CDNA 54.54
- Support Level
- ETJ $8.90
- CDNA $12.45
- Resistance Level
- ETJ $9.04
- CDNA $13.05
- Average True Range (ATR)
- ETJ 0.08
- CDNA 0.61
- MACD
- ETJ 0.00
- CDNA 0.36
- Stochastic Oscillator
- ETJ 64.00
- CDNA 95.64
About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.